← Eichor
Study identifier: NCT06309368 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure

Condition: Surgical Site Infection · Wound Surgical · Colorectal Disorders  ·  Sponsor: University of Nevada, Las Vegas

PhasePhase 4
Planned participants84
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical trial is to compare two types of closure in patients with ostomies that are ready for closure. The main questions it aims to answer are: 1. Surgical site infection rates 2. Patient quality of life 3. Time to wound healing Participants will undergo either complete ostomy wound closure after washing out the wound with Prontosan, or their ostomy wound will be closed using the Pursestring method, where the wound will be left partially open and allowed to heal from the inside out. Researchers will compare these two groups' outcomes (questions to be answered) as listed above.

This description comes directly from the study's public registry record.

Talk to the study team

Abigail W Cheng, MD  ·  9166954159  ·  abigail.cheng@unlv.edu

Lance Horner, MD  ·  7755445456  ·  lance.horner@unlv.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical CenterLas Vegas, Nevada, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06309368